DSG3 and pemphigus: The interpretation of the desmoglein compensation theory, as it relates to the clinical findings in pemphigus, can be summarized as follows: patients with antibodies against only desmoglein 3 should have mucosal-dominant PV because desmoglein 1 compensates for the loss of desmoglein 3 in skin.